Rejeunesse Fine Deep Shape 1.1ml x 1 sy HA 24mg/mL, Lido 0.3%

Product Details

1.1mL x 1syringe | HA 24mg/mL | Lido caine 0.3%

Rejeunesse™ is a non-animal based dermal filler contains hyaluronic acid (HA) at a concentration of 24mg/ml, with the addition of Lido caine at a concentration of 0.3%

Rejeunesse Fine : Needles 30G x 2pcs

Rejeunesse Deep : Needles 27G x 2pcs

Rejeunesse Shape : Needles 26G x 2pcs

Rejeunesse™ with lido caine is a sterile, transparent, pyrogen-free, viscoelastic gel of 100% crosslinked hyaluronic acid of non-animal origin containing 0.3% lido caine hydrochloride for treatment of wrinkles and folds. The lido caine provides the patient’s pain reducing effect during treatment.

• Safety : Rejeunesse™ is non-animal based, crosslinked dermal filler using BDDE for linking agent. Rejeunesse™ product is obtained through our unique UPHEC technology, making it safe and non carcinogenic for humans. Rejeunesse™ contains less than 1.2EU/mL of endotoxins with no BDDE residue detected and it exceeds the highest level of HA purity. Rejeunesse™ is completely free of all animal products thus reducing the risk of an immunogenic reaction.

• Long-lasting : Once injected, HA is gradually broken and absorbed into the body, which is why how strongly HA is crosslinked is crucial to the longevity of the dermal fillers. With unique crosslinking technology, Rejeunesse™ has longevity over 12months.

• Efficacy : Rejeunesse™ offers visible results immediately and stable volume effect with minimized swelling after application.

• Treatment without pain : Rejeunesse™ has optimized the product to minimize the pain during and/or post injection for patients. Monophasic Rejeunesse™ enables smoothest and stable injection during procedure by maintaining consistent injection force. Especially, Rejeunesse™ Lido caine series which combines 0.3% of Lido caine (local an esthetic) minimizes injection pain during the procedure. Thus, it allows patients to experience the most comfortable, almost painless, procedure of dermal fillers.